U
IMPV

UBS’s Imperva, Inc. IMPV Stock Holding History

UBS’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1.55M Buy
53,800
+800
+2% +$21.7K ﹤0.01% 3155
2014
Q2 		$1.39M Buy
+53,000
New +$1.37M ﹤0.01% 3239
2014
Q1 		– Sell
-200
Closed -$10K – 11056
2013
Q4 		$10K Buy
+200
New +$8.41K ﹤0.01% 9024

Other funds holding IMPV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

UBS's IMPV Position: Q3 2014 in Review

UBS reduced its Imperva, Inc. (IMPV) stake by 35% in Q3 2014, selling an estimated $464K and leaving 31,228 shares worth $898K. The position accounts for ﹤0.01% of the portfolio, ranked #3700.

UBS first reported a position in IMPV in Q2 2013 and has held it in 6 quarters since. The position peaked at $2.2M in Q4 2013. 122 funds tracked by Wall St. Rank hold IMPV as of Q3 2014.

  • UBS held 31,228 shares of Imperva, Inc. worth $898K as of Q3 2014.
  • UBS sold 17,095 Imperva, Inc. shares in Q3 2014, an estimated $464K.
  • Imperva, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #3700 holding.
  • UBS first reported a position in Imperva, Inc. in Q2 2013 and has held it in 6 quarters since.
  • UBS's Imperva, Inc. position peaked at $2.2M in Q4 2013.
  • 122 funds tracked by Wall St. Rank held Imperva, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.